Programmable CRISPR tools are turning stem cell biology into something closer to software engineering, shrinking ...

CRISPR Therapeutics recently drew attention as updates highlighted progress in its gene-editing pipeline, including early-stage studies of CTX310, an in vivo therapy designed to lower LDL cholesterol ...

To compete at iGEM, a sort of science Olympics, teens at a Georgia high school set their sights on finding a better way to ...

To the research team working to save him, KJ Muldoon was first known only as Patient Eta. But within months, KJ’s name — and ...

A groundbreaking new treatment using genome-edited immune cells, developed by scientists at UCL (University College London) ...

Liquid biopsy is increasingly recognized as a promising tool for cancer detection and treatment monitoring, yet its ...

This year, gene-editing technology was customized to fix mutations in a single patient’s genes for the first time.

Casgevy, now a "national priority" drug, helped kids with sickle cell and thalassemia, results which may help toward a label ...

For years, Yale researchers David Breslow and Mustafa Khokha have worked together with a similar challenge in their ...

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, has published new research in ...

If you have been wondering whether CRISPR Therapeutics at around $57 a share is a bargain or a bubble, you are not alone. This stock sits at the crossroads of high science and high expectations. The ...

CRISPR, the gene-editing technology which won its creators the 2020 Nobel Prize for Chemistry, is most well-known for its ...